CLINICAL_TRIALS
trial_result
· 2019-02-15
Clinical Trial Update: Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 2]
Summary
Phase 2 trial of sorafenib in metastatic or unresectable kidney cancer was terminated; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Nebraska | Conditions: Kidney Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-02-15